Skip to main content
. 2017 Dec 8;9(90):36057–36066. doi: 10.18632/oncotarget.23282

Figure 5. Aberrant expression of lincRNA-P7 and the overall survival and recurrence-free survival rates.

Figure 5

Kaplan-Meier analyses of the correlations between the lincRNA P7 expression level and overall survival (A) and recurrence-free survival (B) of 108 patients with HCC. The median expression level was used as the cutoff. Patients with lincRNA P7 expression values below the 50th percentile were classified as having lower lincRNA P7 levels. Patients with lincRNA P7 expression value above the 50th percentile were classified as having higher lincRNA P7 levels.